Why I pivoted from COVID-19 back to cancer research

被引：0
|
作者：
Turajlic, Samra [1 ,2 ,3 ]
机构：
[1] Francis Crick Inst, Canc Dynam Lab, London, England
[2] Royal Marsden NHS Fdn Trust, Renal & Skin Units, London, England
[3] Inst Canc Res, Melanoma & Kidney Canc Team, London, England
来源：
NATURE MEDICINE | 2022年 / 28卷 / 09期
关键词：
D O I：
10.1038/s41591-022-01994-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The COVID-19 pandemic showed what can be achieved with clear goals, less bureaucracy and enough funding - important lessons for cancer research.
引用
收藏
页码：1750 / 1750
页数：1
相关论文
共 50 条
  • [1] Why I pivoted from COVID-19 back to cancer research
    Samra Turajlic
    Nature Medicine, 2022, 28 : 1750 - 1750
  • [2] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Saptarshi Sinha
    Chanakya Nath Kundu
    Medical Oncology, 2021, 38
  • [3] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Sinha, Saptarshi
    Kundu, Chanakya Nath
    MEDICAL ONCOLOGY, 2021, 38 (09)
  • [4] How an immunologist pivoted to tackle COVID-19
    Couzin-Frankel, Jennifer
    SCIENCE, 2020, 370 (6516) : 514 - 515
  • [5] COVID-19 and cancer research
    Adrian L. Harris
    British Journal of Cancer, 2020, 123 : 689 - 690
  • [6] COVID-19 and cancer research
    Harris, Adrian L.
    BRITISH JOURNAL OF CANCER, 2020, 123 (05) : 689 - 690
  • [7] Cancer Research: The Lessons to Learn from COVID-19
    Bailey, Chris
    Black, James R. M.
    Swanton, Charles
    CANCER DISCOVERY, 2020, 10 (09) : 1263 - 1266
  • [8] Cancer research, treatment, and COVID-19
    Curley, Steven A.
    Currell, Frederick
    Krishnan, Sunil
    Krpetic, Zeljka
    CANCER NANOTECHNOLOGY, 2020, 11 (01)
  • [9] Cancer research in the midst of COVID-19
    Karl Gruber
    Nature Cancer, 2022, 3 : 1409 - 1411
  • [10] Cancer research, treatment, and COVID-19
    Steven A. Curley
    Frederick Currell
    Sunil Krishnan
    Zeljka Krpetic
    Cancer Nanotechnology, 2020, 11
12345